<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1055</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2019-3-48-52</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Inflationary processes in the pharmaceutical market: development forecasting</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Livansky</surname><given-names>S. M.</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Utyomova</surname><given-names>A. S.</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Denisova</surname><given-names>M. N.</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff id="aff-1"></aff><aff id="aff-2">Federal Budgetary Institution "State Institute of Medicines and Good Practices"</aff><aff id="aff-3">Economics and Analysis of the Pharmaceutical and Medical Industry</aff><aff id="aff-4">Federal State Autonomous Educational Institution of Higher Education "Sechenov First Moscow State Medical University"</aff><aff id="aff-5">IQVIA</aff><pub-date date-type="epub" iso-8601-date="2019-12-03" publication-format="electronic"><day>03</day><month>12</month><year>2019</year></pub-date><issue>3</issue><fpage>48</fpage><lpage>52</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2019,</copyright-statement><copyright-year>2019</copyright-year></permissions><abstract>The article presents a review of the Russian pharmaceutical market development over the past few years from the perspective of the inflationary processes. Key drivers and the degree of their influence on the dynamics of the main market segments are identified. The authors present the drivers that will determine the development of the pharmaceutical market in the future and generate forecasts for the domestic pharmaceutical market development in the midterm based on the scenario approach.</abstract><kwd-group xml:lang="en"><kwd>Russian pharmaceutical market</kwd><kwd>inflation</kwd><kwd>forecast</kwd><kwd>drugs</kwd><kwd>medicines</kwd><kwd>retail market</kwd><kwd>budget segment</kwd><kwd>Vital and Essential Drugs</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>российский фармацевтический рынок</kwd><kwd>инфляция</kwd><kwd>прогноз</kwd><kwd>лекарственные препараты</kwd><kwd>лекарственные средства</kwd><kwd>розничный рынок</kwd><kwd>бюджетный сегмент</kwd><kwd>ЖНВЛП</kwd></kwd-group></article-meta></front><body></body><back/></article>
